{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:15:44Z","timestamp":1768824944806,"version":"3.49.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Nail psoriasis is a common and potentially debilitating condition for which no effective and safe nonsystemic therapy is currently available. Recently, laser-assisted drug delivery (LADD) is being increasingly used to facilitate transcutaneous penetration of topical treatments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVES<\/jats:title>\n            <jats:p>We set to assess the efficacy and safety of combined pulse-dye laser and fractional CO2 laser-assisted betamethasonecalcipotriol gel delivery for the treatment of nail psoriasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIAL AND METHODS<\/jats:title>\n            <jats:p>We conducted a prospective, intrapatient comparative study in a series of 22 patients with bilateral fingernail psoriasis. Nails on the randomized hand were treated with 3 monthly sessions of pulse-dye laser to the proximal and lateral nail folds followed by fractional ablative CO<jats:sub>2<\/jats:sub> laser to the nail plate. Between treatments and one month following the last treatment, the participants applied betamethasone propionate-calcipotriol gel once daily to the nail plate. Clinical outcome was ascertained using nails photography, the Nail Psoriasis Severity Index (NAPSI) and patient satisfaction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Seventeen completed the study. Three participants withdrew from the study because of treatment-associated pain. Treatment was associated with a statistically significant improvement of the NAPSI scale (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; .002). Patient satisfaction was high.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Combined PDL and fractional ablative CO<jats:sub>2<\/jats:sub>-LADD of betamethasone-calcipotriol gel should be considered for the treatment of nail psoriasis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002835","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T16:38:53Z","timestamp":1611247133000},"page":"e111-e116","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Pulse-Dye Laser Followed by Betamethasone-Calcipotriol and Fractional Ablative CO2-Laser-Assisted Delivery for Nail Psoriasis"],"prefix":"10.1097","volume":"47","author":[{"given":"Waseem","family":"Shehadeh","sequence":"first","affiliation":[{"name":"Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagit","family":"Matz","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel;"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eran","family":"Ellenbogen","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel;"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Sprecher","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel;"},{"name":"Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofir","family":"Artzi","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/bjd.12632","article-title":"Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1","volume":"170","author":"Rich","year":"2014","journal-title":"Br J Dermatol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaad.2007.07.042","article-title":"Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year","volume":"58","author":"Rich","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R3-20250731","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2009.03211.x","article-title":"Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis","volume":"23","author":"Luger","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3109\/09546630902789326","article-title":"Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders","volume":"20","author":"Moore","year":"2009","journal-title":"J Dermatol Treat"},{"issue":"Suppl 1","key":"R5-20250731","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000316179","article-title":"Treatment and management of psoriasis with nail involvement: a focus on biologic therapy","volume":"221","author":"Langley","year":"2010","journal-title":"Dermatology"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1346-8138.2011.01347.x","article-title":"Efficacy and safety of ustekinumab in Japanese patients with moderate-to-severe plaque-type psoriasis: long-term results from a phase 2\/3 clinical trial","volume":"39","author":"Igarashi","year":"2012","journal-title":"J Dermatol"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000246274","article-title":"Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients","volume":"193","author":"de Jong","year":"1996","journal-title":"Dermatology"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/0019-5154.135470","article-title":"Nail psoriasis: the journey so far","volume":"59","author":"Dogra","year":"2014","journal-title":"Indian J Dermatol"},{"issue":"Suppl 1","key":"R9-20250731","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1468-3083.2009.03364.x","article-title":"Approach to managing patients with nail psoriasis","volume":"23","author":"Reich","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R10-20250731","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/bjd.13272","article-title":"Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis","volume":"171","author":"Langenbruch","year":"2014","journal-title":"Br J Dermatol"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-4632.2009.04452.x","article-title":"Evaluation of nail disease in psoriatic arthritis by using a modified nail psoriasis severity score index","volume":"49","author":"Maejima","year":"2010","journal-title":"Int J Dermatol"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1468-3083.2010.03938.x","article-title":"Nail psoriasis: a retrospective study on the effectiveness of systemic treatments (classical and biological therapy)","volume":"25","author":"Sanchez-Regana","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R13-20250731","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/1346-8138.12201","article-title":"Identification of psoriatic patients at risk of high quality of life impairment","volume":"40","author":"Sojevic Timotijevic","year":"2013","journal-title":"J Dermatol"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1468-3083.2009.03453.x","article-title":"Treatment of nail psoriasis with adalimumab: an open label unblinded study","volume":"24","author":"Rigopoulos","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R15-20250731","first-page":"279","article-title":"Calcipotriol used as monotherapy or combination therapy with betamethasone dipropionate in the treatment of nail psoriasis","volume":"88","author":"Tzung","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4103\/0378-6323.174389","article-title":"Effective treatment of severe nail psoriasis using topical calcipotriol with betamethasone dipropionate gel","volume":"82","author":"Tan","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000202179","article-title":"Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment","volume":"218","author":"Rigopoulos","year":"2009","journal-title":"Dermatology"},{"key":"R18-20250731","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00015550252948220","article-title":"Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream","volume":"82","author":"Rigopoulos","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"R19-20250731","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1365-2133.1998.02462.x","article-title":"Calcipotriol ointment in nail psoriasis: a controlled double-blind comparison with betamethasone dipropionate and salicylic acid","volume":"139","author":"Tosti","year":"1998","journal-title":"Br J Dermatol"},{"key":"R20-20250731","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ad.2012.04.008","article-title":"Nail psoriasis: treatment with tazarotene 0.1% hydrophilic ointment","volume":"103","author":"Fischer-Levancini","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"R21-20250731","first-page":"355","article-title":"Tazarotene 0.1% gel in the treatment of fingernail psoriasis: a double-blind, randomized, vehicle-controlled study","volume":"68","author":"Scher","year":"2001","journal-title":"Cutis"},{"key":"R22-20250731","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2133.2003.05392.x","article-title":"Tazarotene 0\u00b7 1% gel for psoriasis of the fingernails and toenails: an open, prospective study","volume":"149","author":"Bianchi","year":"2003","journal-title":"Br J Dermatol"},{"key":"R23-20250731","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/lsm.22122","article-title":"Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study","volume":"45","author":"Huang","year":"2013","journal-title":"Lasers Surg Med"},{"key":"R24-20250731","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaad.2019.01.072","article-title":"Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: a dermatologist and nail expert group consensus","volume":"81","author":"Rigopoulos","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"R25-20250731","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/ijdvl.IJDVL_73_16","article-title":"Intramatricial injections for nail psoriasis: an open-label comparative study of triamcinolone, methotrexate, and cyclosporine","volume":"84","author":"Mittal","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R26-20250731","doi-asserted-by":"crossref","DOI":"10.5070\/D3252042885","article-title":"Laser-assisted drug delivery for the treatment of androgenetic alopecia: ablative laser fractional photothermolysis to enhance cutaneous topical delivery of platelet-rich plasma with or without concurrent bimatoprost and\/or minoxidil","volume":"25","author":"Cohen","year":"2019","journal-title":"Dermatol Online J"},{"key":"R27-20250731","first-page":"663","article-title":"Laser-assisted delivery of topical cidofovir in the treatment of plantar warts","volume":"18","author":"Coates","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"R28-20250731","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jdcr.2019.07.010","article-title":"Laser-assisted drug delivery in the treatment of keloids: a case of extensive refractory keloids successfully treated with fractional carbon dioxide laser followed by topical application and intralesional injection of steroid suspension","volume":"5","author":"Al Janahi","year":"2019","journal-title":"JAAD Case Rep"},{"key":"R29-20250731","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2340\/00015555-2874","article-title":"Laser-assisted photodynamic therapy or laser-assisted amorolfine lacquer delivery for treatment of toenail onychomycosis: an open-label comparative study","volume":"98","author":"Koren","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"R30-20250731","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/09546634.2018.1509046","article-title":"Fractional carbon dioxide laser assisted delivery of topical tazarotene versus topical tioconazole in the treatment of onychomycosis","volume":"30","author":"Abd El-Aal","year":"2019","journal-title":"J Dermatol Treat"},{"key":"R31-20250731","first-page":"123","article-title":"The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis","volume":"34","author":"Cassell","year":"2007","journal-title":"J Rheumatol"},{"key":"R32-20250731","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1468-3083.2009.03196.x","article-title":"Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study","volume":"23","author":"Fernandez-Guarino","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R33-20250731","doi-asserted-by":"crossref","DOI":"10.3109\/14764172.2013.854627","article-title":"Clinical trial study in the treatment of nail psoriasis with pulsed dye laser","author":"Goldust","year":"2013","journal-title":"J Cosmet Laser Ther"},{"key":"R34-20250731","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jaad.2011.12.015","article-title":"The effect of different pulse durations in the treatment of nail psoriasis with 595-nm pulsed dye laser: a randomized, double blind, intra patient left-to-right study","volume":"66","author":"Treewittayapoom","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R35-20250731","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s13555-014-0057-y","article-title":"Single blinded left-to-right comparison study of excimer laser versus pulsed dye laser for the treatment of nail psoriasis","volume":"4","author":"Al-Mutairi","year":"2014","journal-title":"Dermatol Ther (Heidelb)"},{"key":"R36-20250731","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ad.2016.09.009","article-title":"Treatment of nail psoriasis with Pulse Dye Laser plus calcipotriol betametasona gel vs Nd: YAG plus calcipotriol betamethasone gel: an intrapatient left-to-right controlled study","volume":"108","author":"Arango-Duque","year":"2017","journal-title":"Actas Dermosifliogr"},{"key":"R37-20250731","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/lsm.22122","article-title":"Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: a single-blind, intrapatient left-to-right controlled study","volume":"45","author":"Huang","year":"2013","journal-title":"Lasers Surg Med"},{"key":"R38-20250731","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ad.2018.07.008","article-title":"Laser-assisted drug delivery","volume":"109","author":"Alegre-S\u00e1nchez","year":"2018","journal-title":"Actas Dermosifiliogr"},{"key":"R39-20250731","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/DSS.0000000000001678","article-title":"Treatment of hypertrophic scars using laser-assisted corticosteroid versus laser-assisted 5-fluorouracil delivery","volume":"45","author":"Waibel","year":"2019","journal-title":"Dermatol Surg"},{"key":"R40-20250731","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijpharm.2017.09.048","article-title":"Effect of ablative laser on in vitro transungual delivery","volume":"544","author":"Nguyen","year":"2018","journal-title":"Int J Pharm"},{"key":"R41-20250731","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/DSS.0000000000001289","article-title":"Commentary on long-pulsed Nd: YAG laser treatment for nail psoriasis","volume":"44","author":"Knackstedt","year":"2018","journal-title":"Dermatol Surg"},{"key":"R42-20250731","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1590\/abd1806-4841.20175918","article-title":"Nail psoriasis treated with pulsed dye laser","volume":"92","author":"Peruzzo","year":"2017","journal-title":"An Bras Dermatol"},{"key":"R43-20250731","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/jdv.13678","article-title":"Laser and light therapies for the treatment of nail psoriasis","volume":"30","author":"Maranda","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R44-20250731","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/0019-5154.127699","article-title":"Pulsed dye laser for nail psoriasis: not the first time and apparently not that efficacious!","volume":"59","author":"Sonthalia","year":"2014","journal-title":"Indian J Dermatol"},{"key":"R45-20250731","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/DSS.0000000000000841","article-title":"A clinical review of laser and light therapy for nail psoriasis and onychomycosis","volume":"43","author":"Wiznia","year":"2017","journal-title":"Dermatol Surg"},{"key":"R46-20250731","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1524-4725.2009.01448.x","article-title":"Pulsed dye laser in the treatment of nail psoriasis","volume":"36","author":"Oram","year":"2010","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:12:50Z","timestamp":1753999970000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002835","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]}}}